IP Library Granted Patent US 8,889,113
Granted Patent B2
US 8,889,113 · App. 13/596,773 · Granted Nov 18, 2014

Compositions and kits for the removal of irritating compounds from bodily surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,113
App. No.
13/596,773
Granted
Nov 18, 2014
Kind
B2
Abstract

The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.

Claims (17)

1. A method for removing capsaicin from a bodily surface comprising:

topically applying a surfactant-free gel composition to the bodily surface, the bodily surface having capsaicin thereon;

wiping the surfactant-free composition off the bodily surface after the surfactant-free gel composition has been on the bodily surface for a time period sufficient to solubilize at least 10% w/w of the capsaicin,

wherein the surfactant-free gel composition comprises 80 to 95 percent w/w polyethylene glycol and has a viscosity of between 4000 cps to 8000 cps.

2. The method of claim 1 , wherein the surfactant-free gel composition has a viscosity of 4000 cps.

3. The method of claim 1 , wherein the surfactant-free gel composition has a viscosity of 5000 cps.

4. The method of claim 1 , wherein the surfactant-free gel composition has a viscosity of 8000 cps.

5. The method of claim 1 , wherein at least 20 percent w/w of the capsaicin is solubilized in the surfactant-free gel composition.

6. The method of claim 5 , wherein at least 25 percent w/w of the capsaicin is solubilized in the surfactant-free gel composition.

7. The method of claim 1 , wherein the surfactant-free gel composition is impregnated in a porous substrate.

8. The method of claim 7 , wherein the porous substrate is a towellette.

9. The method of claim 1 , wherein 50 gm of the surfactant-free gel composition is topically applied to the bodily surface.

10. The method of claim 1 , wherein the bodily surface is the skin, eyes, or a mucous membrane.

11. The method of claim 10 , wherein the bodily surface is the skin.

12. The method of claim 1 , wherein the capsaicin on the bodily surface is supplied by a composition comprising 0.001 to 60 percent w/w capsaicin.

13. The method of claim 12 , wherein the composition is a patch.

14. The method of claim 12 , wherein the composition is a lotion.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: GRÜNENTHAL GMBH
To: AVERITAS PHARMA INC.
Reel/Frame 050065/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2019
From: ACORDA THERAPEUTICS, INC.
To: GRÜNENTHAL GMBH
Reel/Frame 049260/0707 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
SECURITY INTEREST Recorded Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 032726/0626 →
ASSIGNMENT AND RELEASE OF SECURITY INTEREST Recorded Jul 10, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: NEUROGESX, INC.
Reel/Frame 030777/0782 →
SECURITY AGREEMENT Recorded Nov 13, 2012
From: NEUROGESX, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 029291/0807 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: BLEY, KEITH R.; WILCOX, ALLAN L.; JAMIESON, GENE C.; MUHAMMAD, NAWEED
To: NEUROGESX, INC.
Reel/Frame 028871/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: ANGEL, ARTURO J.; LITLE, LARRY W.
To: DOW PHARMACEUTICAL SCIENCES
Reel/Frame 028871/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: DOW PHARMACEUTICAL SCIENCES
To: NEUROGESX, INC.
Reel/Frame 028872/0003 →